ANTIBODIES | PERITO NEAL SPECIM ENS | ASCITES | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | TS-266 | TS-265 | TS-235 | TS-236 | TS-267 | TS-242 | TS-256 | M eans | ASC290 | ASC288 | ASC278 | Means |
CD68+/CCR1+ | 65 | 51 | 45 | 44 | 76 | 58 | 83 | 60.3 | 87 | 77 | 78 | 80.7 |
CD68+/IL8+ | 61 | 35 | 38 | 36 | 45 | 66 | 74 | 50.7 | 55 | 52 | 42 | 49.7 |
CD68+/CCR1+IL8+ | 66 | 38 | 28 | 30 | 46 | 42 | 37 | 41 | 45 | 35 | 48 | 42.7 |
CD3+/CCR1+ | 53 | 19 | 18 | 6 | 2 | 0 | 8 | 15.1 | 0 | 10 | 2 | 4 |
CD3+/IL8+ | 80 | 45 | 19 | 34 | 7 | 4 | 8 | 28.1 | 0 | 10 | 2 | 4 |
CD3+/CCR1+IL8+ | 47 | 24 | 5 | 11 | 0 | 0 | 0 | 12.4 | 0 | 10 | 2 | 4 |
CD68+/CD163+ | 19 | 38 | 31 | 43 | 67 | 39 | 78 | 45 | 30 | 36 | 91 | 52.3 |
CD163+/IL8+ | 22 | 7 | 0 | 20 | 11 | 45 | 22 | 18.1 | 60 | 65 | 26 | 50.3 |
CD68+/CD163+IL8+ | 5 | 3 | 0 | 9 | 4 | 22 | 19 | 8.9 | 15 | 29 | 32 | 25.3 |
CD68+/VCAM1+ | 59 | 94 | 68 | 60 | 55 | 4 | 29 | 52.7 | 79 | 81 | 26 | 62 |
CD68+/CD3+ | 1 | 0 | 1 | 2 | 0 | 6 | 3 | 1.9 | 19 | 33 | 15 | 22.3 |
CD3+/VCAM1+ | 4 | 0 | 5 | 4 | 0 | 0 | 12 | 3.6 | 38 | 69 | 31 | 46 |
CD68+/CD3+VCAM1+ | 1 | 0 | 1 | 0 | 0 | 0 | 2 | 0.6 | 16 | 31 | 9 | 18.7 |
CD3/CD68 Ratio | 1 to 2 | 1 to 11 | 1 to 4 | 1 to 4 | 1 to 2 | 1 to 2 | 1 to 8 | Â | 1 to 2 | 1 to 2 | 1 to 2 | Â |
Disease Stage | III | III | III | III | III | II | II | Â | III | III | III | Â |
Histology | C | E | S/E | S/E | S | S/E | E | Â | S | S | S | Â |